General information about the research study
When was the study done? difficulty breathing and might even require a
child to be admitted to the hospital. More than
The study started in January 2017 and ended in half of all infants are infected with RSV during the
November 2020. first year of their lives. Almost all children are
infected with RSV by their second birthday.
Why was this study done? Vaccines may be a way to help protect against
RSV. They contain parts of RSV that cannot cause
RSV (respiratory syncytial virus) can infect the
infection. These parts help the body make
airways and lungs. RSV is spread from person to
defenses, known as antibodies, against RSV.
person mostly by coughing and sneezing. It may
The main goal of the study was to assess the
lead to a runny nose, fever, cough, difficulty in
safety of RSV vaccine.
breathing and loss of appetite. Infants, young
children and older people are most likely to have This report focuses on the results of the main
a severe RSV infection. In young children, this goals of the study. All results may be found in the
severe infection can cause wheezing and clinical results summary.
Who took part in this study?
82 children from 8 countries
12 to 23 months old when they
got their first vaccination
41 girls (50%)
41 boys (50%)
Children could take part in the study if Children could not take part in the study if
they: they:
were in good health had birth defects or a weak immune system
were born full-term received any experimental vaccine or a drug
within 30 days before study
had RSV antibodies in their blood
were allowed by their parents to participate
in the study